University of Minnesota. Driven to Discover.
Earlier this week, a leading expert voiced similar concerns, noting that the WHO hadn't made its voice heard.
The new dengue subtype is the first in 50 years and could complicate vaccine development.
(CIDRAP News) – A closely watched first clinical trial of a dengue vaccine showed disappointing efficacy results overall, researchers reported yesterday, but higher efficacy against certain strains.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.